Screening for Albuminuria at the First Line for Early Identification of CKD

CompletedOBSERVATIONAL
Enrollment

141

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

July 30, 2024

Conditions
Chronic Kidney DiseasesAlbuminuria
Interventions
DIAGNOSTIC_TEST

Albuminuria test

During participation, subjects are asked to collect one or more urine samples for albuminuria determination.

DIAGNOSTIC_TEST

HbA1c test

During the screening visit, HbA1c will be measured with a point-of-care test (Affinion HbA1c, Abbott).

DIAGNOSTIC_TEST

Creatinine test

During the screening visit, creatinine will be measured with a point-of-care test (i-STAT Alinity handheld analyser, Abbott).

Trial Locations (1)

9713GH

General Practitioners Research Institute, Groningen

All Listed Sponsors
collaborator

University Medical Center Groningen

OTHER

lead

General Practitioners Research Institute

NETWORK

NCT05321095 - Screening for Albuminuria at the First Line for Early Identification of CKD | Biotech Hunter | Biotech Hunter